Page last updated: 2024-11-05

ticlopidine and Allergic Acute Coronary Syndrome

ticlopidine has been researched along with Allergic Acute Coronary Syndrome in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research Excerpts

ExcerptRelevanceReference
"Although Kounis syndrome is a rare phenomenon, physicians should be aware of its physiopathological mechanisms in order to treat it appropriately."1.46Management of Kounis syndrome: two case reports. ( Chebili, N; Kraiem, H; Mejri, O; Naija, M; Omri, M, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Omri, M1
Kraiem, H1
Mejri, O1
Naija, M1
Chebili, N1

Other Studies

1 other study available for ticlopidine and Allergic Acute Coronary Syndrome

ArticleYear
Management of Kounis syndrome: two case reports.
    Journal of medical case reports, 2017, May-23, Volume: 11, Issue:1

    Topics: Amoxicillin; Anaphylaxis; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Chest Pain; Clopidogrel

2017